DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Operating Expenses Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual operating expenses in 2023 was 158.62 Million TWD , down -12.03% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly operating expenses in 2024 Q3 was 39.29 Million TWD , down -2.03% from previous quarter.
  • DIVA Laboratories, Ltd. reported a annual operating expenses of 180.31 Million TWD in annual operating expenses 2022, up 14.35% from previous year.
  • DIVA Laboratories, Ltd. reported a annual operating expenses of 157.69 Million TWD in annual operating expenses 2021, up 8.99% from previous year.
  • DIVA Laboratories, Ltd. reported a quarterly operating expenses of 40.77 Million TWD for 2024 Q1, up 84.11% from previous quarter.
  • DIVA Laboratories, Ltd. reported a quarterly operating expenses of 40.1 Million TWD for 2024 Q2, down -1.65% from previous quarter.

Annual Operating Expenses Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Operating Expenses of DIVA Laboratories, Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 158.62 Million TWD -12.03%
2022 180.31 Million TWD 14.35%
2021 157.69 Million TWD 8.99%
2020 144.68 Million TWD -9.04%
2019 159.07 Million TWD 0.0%

Peer Operating Expenses Comparison of DIVA Laboratories, Ltd.

Name Operating Expenses Operating Expenses Difference
BIONET Corp. 553.58 Million TWD 71.347%
Genetics Generation Advancement Corp. 218.25 Million TWD 27.323%
Welgene Biotech Co.,Ltd. 123.97 Million TWD -27.946%
Puriblood Medical Co., Ltd. 56.92 Million TWD -178.644%
TFBS Bioscience Inc. 77.82 Million TWD -103.807%